Search research articles
Contact Us
Filters
Showing results (1-10 of 625) with videos related to
Page
of 63
Sort By:
International Journal of Law and Psychiatry
|
January 1, 1986
Criminological appraisals of psychiatric explanations of crime: 1936-1950
C Goff
JAMA
|
June 22, 2002
A 23-year-old man with schizophrenia
Donald C Goff
Schizophrenia Bulletin
|
February 28, 2012
D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia
Donald C Goff
JAMA
|
November 27, 1996
Referral of patients with myocardial infarction and low ejection fraction to arrhythmia specialists
D C Goff
JAMA Psychiatry
|
April 4, 2014
Bitopertin: the good news and bad news
Donald C Goff
The New England Journal of Medicine
|
April 16, 2020
Promising Evidence of Antipsychotic Efficacy without Dopamine D2-Receptor Binding
Donald C Goff
Current Opinion in Psychiatry
|
February 25, 2015
Drug development in schizophrenia: are glutamatergic targets still worth aiming at?
Donald C Goff
Archives of Internal Medicine
|
November 30, 2011
Glycemic control and cardiorenal outcomes in patients with advanced chronic kidney disease: relative or absolute risks?: comment on "Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease"
David C Goff
Journal of Biochemistry
|
January 1, 1975
Proceedings: Modification of E. coli RNA polymerase induced by T4 phage infection
G C Goff
The American Journal of Psychiatry
|
August 5, 2008
New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life
Donald C Goff
Page
of 63
Search research articles
Search
Showing results (1-10 of 625) with videos related to
Sort By:
Page
of 63
International Journal of Law and Psychiatry
|
January 1, 1986
Criminological appraisals of psychiatric explanations of crime: 1936-1950
C Goff
JAMA
|
June 22, 2002
A 23-year-old man with schizophrenia
Donald C Goff
Schizophrenia Bulletin
|
February 28, 2012
D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia
Donald C Goff
JAMA
|
November 27, 1996
Referral of patients with myocardial infarction and low ejection fraction to arrhythmia specialists
D C Goff
JAMA Psychiatry
|
April 4, 2014
Bitopertin: the good news and bad news
Donald C Goff
The New England Journal of Medicine
|
April 16, 2020
Promising Evidence of Antipsychotic Efficacy without Dopamine D2-Receptor Binding
Donald C Goff
Current Opinion in Psychiatry
|
February 25, 2015
Drug development in schizophrenia: are glutamatergic targets still worth aiming at?
Donald C Goff
Archives of Internal Medicine
|
November 30, 2011
Glycemic control and cardiorenal outcomes in patients with advanced chronic kidney disease: relative or absolute risks?: comment on "Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease"
David C Goff
Journal of Biochemistry
|
January 1, 1975
Proceedings: Modification of E. coli RNA polymerase induced by T4 phage infection
G C Goff
The American Journal of Psychiatry
|
August 5, 2008
New insights into clinical response in schizophrenia: from dopamine D2 receptor occupancy to patients' quality of life
Donald C Goff
Page
of 63